Brief: Vir Biotechnology Appoints David Liu As Chief Medical Officer
07/10/2026 13:45
BRIEF-Vir Biotechnology Appoints David Liu As Chief Medical Officer Oct 7 (Reuters) - Vir Biotechnology, Inc. VIR.O:
VIR BIOTECHNOLOGY APPOINTS DAVID LIU AS CHIEF MEDICAL OFFICER
Source text: ID:nBw9vsQGRa
Further company coverage: VIR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vir Biotechnology
See all newsVir, Gilead team up on solid tumor cancer therapies in up to $1.9 billion deal
Vir Biotechnology gains after up to $1.9 billion licensing deal with Gilead
Brief: Vir Biotechnology Announces Psma-Targeted Pro-Xten® Dual-Masked T-Cell Engager Vir-5500 Received FDA Fast Track Designation For The Treatment Of Prostate Cancer
Brief: Vir Biotechnology Appoints David Liu As Chief Medical Officer
Vir Biotechnology rises after naming Theravance's Sawaf as CFO